Difference between revisions of "Troy Cox"
From QueerBio.com
| Line 1: | Line 1: | ||
| − | [[File: | + | [[File:troycox.jpg|200px|thumb|left|Troy Cox]] |
==Country== | ==Country== | ||
| Line 18: | Line 18: | ||
==See Also== | ==See Also== | ||
| − | * [[ | + | * [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]] |
==Further Reading/Research== | ==Further Reading/Research== | ||
Revision as of 17:18, 1 January 2024
Country
United States
Birth - Death
Occupation
Business
Description
Board member of SomaLogic, Biosplice Therapeutics, Sophia Genetics, and LetsGetChecked. Former President and CEO of Foundation Medicine from early 2017 through the acquisition by Roche valuing FMI at $5.3 billion. Former Senior Vice President and Officer at Genentech; leading U.S. Before Genentech, he held executive and senior roles of increasingly broad accountabilities including President of UCB BioPharmaceuticals, Senior Vice President of Sanofi-Aventis, and diverse foundational roles at Schering-Plough.